QDEL

#2579
QuidelOrtho Corporation Common Stock
11.8300 USD
-32.36%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
11.6140
11.9799
Year Range
11.6140
35.5750
Daily Change
-32.36%
Monthly Change
-33.76%
6 month change
-61.23%
Year Change
-61.23%
Previous Close
17.4900
Open
11.9050
Bid
Ask
Low
11.6140
High
11.9799
Volume
1 885
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 805.4073 M
  • Employee 6 500
  • Founded 1979
  • CEO Douglas C Bryant
  • Website www.quidelortho.com
  • Headquarter California, United States
  • FIGI BBG017TGV7M2
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.76
Price to sales ratio
0.73

QuidelOrtho Corporation

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

News